Cyltezo

Cyltezo (adalimumab-adbm) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Cyltezo is an interchangeable biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Cyltezo may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Get Cyltezo for as low as $19,683.21, save up to 80% off the average retail price for the most common version, by using a GoodRx coupon.